Discover more from Dr. Panda's Newsletter
Another Vaccine Failure?
Monkeypox Cluster in Chicago - 9 out of 13 cases FULLY VACCINATED
Another failed vaccine?
A cluster of monkeypox (mpox) cases has been identified in Chicago — 69% of the individuals were ‘fully vaccinated.’
On May 11, 2023, the World Health Organization (WHO) declared that the monkeypox outbreak was no longer a global health emergency. However, just days later, the Centers for Disease Control and Prevention (CDC) issued a health alert warning that the outbreak was not over.
The WHO's decision to downgrade the monkeypox outbreak was based on several factors, including the fact the number of new cases has been declining in recent weeks. However, the CDC's health alert warning highlighted the fact that the outbreak is still ongoing and that there is still a risk of transmission.
Today, the CDC is investigating a cluster of monkeypox cases in the Chicago area. From April 17 to May 5, 2023, a total of 12 confirmed and one probable case of monkeypox were reported to the Chicago Department of Public Health (CDPH). All cases were among symptomatic men. None of the patients have been hospitalized.
Most Cases In Fully Vaccinated Men
Nine (69%) of the 13 cases were among men who were considered “fully vaccinated” — they have received two doses of the Jynneos vaccine, which is approved for the prevention of monkeypox and smallpox.
According to studies, cited by the CDC, the Jynneos vaccine has been estimated to be 85.9% effective against mpox. At one dose, the vaccine was found to be 75.2% effective.
However, a real-world study also conducted by the CDC and published in the New England Journal of Medicine found that the Jynneos vaccine was only 66.0% after two doses and 35.8% effective after a single dose at preventing monkeypox.
Dr. Christopher Braden, mpox response incident manager at the CDC says: “It will help individuals prevent the acquisition of mpox and it will help individuals avoid severe disease or even death.”
Despite questions about the efficacy of the vaccine, the CDC still recommends two doses.
Real-world results are drastically lower. Sound Familiar?
The Jynneos vaccine has not been widely used before last summer’s outbreak of mpox. Although it appeared highly effective based on study data and real world assessments, its actual efficacy is in question. Similar to the COVID vaccine's inability to halt transmission, this vaccine also falls short in preventing the spread of the disease. According to the CDC, the monkeypox vaccine has been deemed effective in preventing monkeypox, but this cluster in Chicago proves otherwise.
The CDC is forecasting a potential "resurgence" of monkeypox ahead of summer ‘gatherings.’ It is my guess you will see a resurgence mainly in those ‘fully vaccinated’.
This seems to be another case of vaccinate now, ask questions later.
Funny how vaccines these days don't actually prevent the thing they are supposed to prevent.
I’m so glad you're here! I hope you're enjoying this Substack. If you are, please consider sharing the link with your friends and colleagues. And if you're able, please consider becoming a paid subscriber. For just $5.00 per month, you can help continue my research and reporting. Your support is greatly appreciated.
My previous stack on monkeypox from 2022. FDA provided an EUA to split one dose into 5.
Update: Monkeypox vaccine JYNNEOS fails to make antibodies. Link